Caxton Corporation’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,353
Closed -$205K 13
2023
Q4
$205K Sell
7,353
-5,119
-41% -$143K 1.11% 7
2023
Q3
$266K Buy
+12,472
New +$266K 1.01% 5